Public Access
Public Access
The American Society of Hematology supports free access to Blood on the broadest possible basis. Although ASH cannot adopt or support a publishing model that is not economically sustainable over the long run, certain sections of the journal are always free online:
- Abstracts and tables of contents
- Inside Blood commentaries
- How I Treat articles
- 5 free research articles every issue
Blood maintains a 12-month embargo for current articles, but content older than 12 months is free to all online.
back to top
Patient Information
Although we are unable to provide answers to specific and/or individual questions about hematological problems, conditions, diagnoses, or treatments, the American Society of Hematology, publisher of Blood, provides links to several third-party websites offering information relating to blood diseases and related disorders. Please visit the Patient Resources section of the ASH website for further information.
Patients interested in obtaining a copy of an access-controlled article in Blood that may be helpful to their situation may do so by e-mailing a request to the publishing{at}hematology.org. The request should include the following information:
- Article citation information, including author(s), title of article, issue date & page number (example: Rafik Terra et al., T-cell generation by lymph node resident progenitor cells, July 1, 2005, p. 193). All citation information can be found with the article or abstract information online.
- Your name and email address
- Name of treating physician (optional)
back to top
Funded Research Options
ASH has developed an agreement with the National Institutes of Health (NIH) that provides an option to comply with the NIH policy on enhanced access. All Blood authors who published NIH-funded articles from May 2005 forward have no obligation to submit manuscripts to the NIH archive because Blood will do this, at no charge to the author, on their behalf. This option, the PMC (NIH Portfolio) Archive Program, is the result of efforts by ASH and a group of nonprofit publishers to improve compliance with the current NIH public access policy while maintaining the publisher-mandated access embargoes. The program provides NIH with final articles representing NIH-funded research for an internal use archive at NIH. Authors must acknowledge explicitly in the text (i.e., Acknowledgement section of the article) of their research article that (a) the research in the article they authored was funded by NIH and (b) and/or their institutional affiliation with NIH in order for ASH to deliver your article to PMC shortly after final publication. ASH will instruct PMC to render the research article publicly available 12 months after final publication. This period of time is consistent with ASH’s publication embargo and ensures compliance with author copyright agreements with ASH.
ASH believes the PMC (NIH Portfolio) Archive program provides a better alternative for authors and journals than a mandated policy with a shorter embargo period. ASH continues to work with the NIH on ways to enhance access.
NIH Public Access Frequently Asked Questions
Howard Hughes Medical Institute
ASH has implemented a public access policy in which Howard Hughes Medical Institute-funded papers are deposited into PMC and have immediate and free access on the Blood Web site on payment of the $2,000 public access fee, in addition to the regular publication fees charged to authors. Authors must acknowledge explicitly in the text (i.e., Acknowledgement section) of their research articles that (a) the research in the article they authored was funded by Howard Hughes Medical Institute and (b) and/or their institutional affiliation with Howard Hughes Medical Institute in order for ASH to deliver your article to PMC shortly after final publication. Authors can find out more information about funded research access options for Blood during the manuscript submission process.
Wellcome Trust
ASH has implemented a public access policy in which Wellcome Trust-funded papers are deposited into PMC and have immediate and free access on the Blood website on payment of the $2,000 public access fee, in addition to the regular publication fees charged to authors. To further ensure author compliance with Wellcome Trust’s open-access policies, special licensing language has been drafted to allow end-users of Wellcome-funded articles unrestricted access to these articles. Authors must acknowledge explicitly in the text (i.e., Acknowledgement section of the article) of their research article that (a) the research in the article they authored was funded by Wellcome Trust (b) and/or their institutional affiliation with Wellcome Trust in order for ASH to deliver your article to PMC shortly after final publication. Authors can find out more information about funded research access options for Blood during the manuscript submission process.
back to top
ASH Author Choice
ASH has extended its public access option to any author who would like their article to be immediate and freely available at publication. Upon payment of the $2,000 public access fee, in addition to the regular publication fees charged to authors, ASH will deposit the final, published version of the article into PMC and ensure free and immediate access to the article on the Blood Web site. Authors can find out more information about the public-access policy for Blood during the manuscript submission process.
back to top
Blood Online Legacy Content
ASH has published online all legacy content going back to the first Blood issue in 1946, as searchable PDF files. These files are freely accessible to everyone.
back to top
Pay-per-view
Non-subscribers may choose to access an individual article by using Blood’s pay-per-view option. Pay-per-view options will appear when looking at article or abstract information.
back to top
